Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionQrg Capital Management, Inc.
Latest Disclosed Ownership142,431 shares
Latest Disclosed Value $ 5,234,328
Qrg Capital Management, Inc. reports 29.15% increase in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On April 27, 2026 - Qrg Capital Management, Inc. filed a 13F-HR form disclosing ownership of 142,431 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $4,493,698 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 110,286 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 29.15% during the quarter. The current value of the position is $5,101,878 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 142,431 32,145 29.15 5,234 -6.72 0.0540
2026-02-02 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 110,286 -19,045 -14.73 5,611 -21.81 0.0625
2025-10-28 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 129,331 -103,385 -44.43 7,177 -55.32 0.0869
2025-07-21 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 232,716 1,480 0.64 16,062 0.03 0.1402
2025-04-17 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 231,236 -20,600 -8.18 16,057 -25.87 0.1666
2025-02-05 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 251,836 2,032 0.81 21,663 -27.17 0.2230
2024-10-30 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 249,804 6,844 2.82 29,744 -14.23 0.3214
2024-07-12 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 242,960 9,964 4.28 34,680 15.92 0.4113
2024-05-07 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 232,996 5,821 2.56 29,917 27.30 0.3799
2024-02-07 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 227,175 29,587 14.97 23,501 30.79 0.3484
2023-11-13 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 197,588 197,588 17,969 0.3116
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.